Source: ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021



Rating:

Share or cite this content

Citations should be made in the following way:
Estee P.M. Lau, Matin Eshraghi, Kirstie Dootson, Cindy Yeoh, Wint Ywe Phu, Y.C. Gary Lee, Natalia D. Popowicz. An international survey on the use of intrapleural tissue plasminogen activator/DNase therapy for pleural infection. ERJ Open Res, 8 (1) 00590-2021; 10.1183/23120541.00590-2021

Member's Comments

No comment yet.

Related content which might interest you: Comparison of intrapleural use of urokinase and tissue plasminogen activator/DNAse in pleural infection Source: ERJ Open Res, 5 (3) 00084-2019; 10.1183/23120541.00084-2019 Year: 2019 Variable adoption of intrapleural fibrinolytic therapy for pleural space infections Source: International Congress 2018 – Pleural interventions Year: 2018 Intrapleural use of dornase alfa and tissue plasminogen activator are successful as treatment in pediatric empyema: a pilot study Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 The biological effect of intrapleural tissue plasminogen (tPA) activator and DNase delivery in pleural infection patients. Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies Year: 2018 A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 A multicentre study evaluating bleeding risk with intrapleural enzyme therapy in pleural infection (RETROLYSIS) Source: Virtual Congress 2021 – Novelties in interventional pulmonology Year: 2021 Effectiveness and safety of tissue plasminogen activators (t-PA) in complicated pleural effusion (CPE), what the correlation with time it stays in the pleural space? Source: Annual Congress 2013 –A modern approach to lung diseases: from bronchi to pleura Year: 2013 Outcomes of intrapleural tissue plasminogen activator (tPA) and deoxyribnuclease (DNase) for IPC-related pleural infection Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Respiratory functional status after intrapleural t-PA administration for complicated parapneumonic effusions Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Intrapleural fibrinolytic treatment with streptokinase for empyema during pregnancy: 2 cases Source: Annual Congress 2010 - Infections and pleural problems Year: 2010 Safety and efficacy of reduced dose intrapleural alteplase and DNAase for pleural infection Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Intrapleural urokinase in the management of empyema in children Source: Eur Respir J 2004; 24: Suppl. 48, 620s Year: 2004 Intrapleural streptokinase in the management of loculated pleural fluids of various aetiologies Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 The effect of intrapleural fibrinolytic therapy in the drainage of loculated haemorrhagic effusions Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001 Intrapleural fibrinolytic treatment of empyemas Source: Eur Respir J 2005; 26: Suppl. 49, 491s Year: 2005 Efficacy of thrombolytic agents in the treatment of pulmonary embolism Source: Eur Respir J 2005; 26: 864-874 Year: 2005 Intrapleural tPA increases pleural fluid output in pleural infection, independent of chest X-ray opacification Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Primary thoracoscopy versus fibrinolysis in the management of pleural sepsis Source: Eur Respir J 2004; 24: Suppl. 48, 51s Year: 2004 Multicenter review suggests tunneled pleural catheter use in antineoplastic therapy-related immunosuppression does not increase infection rate Source: International Congress 2018 – Pleural interventions Year: 2018 Ten years experience of use of intrapleural streptokinase (IPSK) for empyema Source: Eur Respir J 2001; 18: Suppl. 33, 319s Year: 2001